Skip to main content

CNO Financial Group, Inc.

For the period ended Sep 30, 2025. Filed Nov 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 6, 2025

CNO$57.16+3.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 5. Other Information

Rule 10b5-1 Trading Arrangements

During the three months ended September 30, 2025, certain officers (as defined in Rule 16a-1(f) of the Exchange Act) (the "Section 16 officers") of the Company adopted separate Rule 10b5-1 trading arrangements (as defined in Item 408(a) of Regulation S-K) for the sale of the Company’s common stock. The following summarizes the material terms of such Rule 10b5-1 trading arrangements, which are intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act and the Company’s policies regarding transactions in Company securities:

Name and title of officerDate of trading arrangementDuration of trading arrangement (a)Aggregate shares of common stock to be sold pursuant to the trading arrangement (b)
Gary C. BhojwaniAugust 21, 2025May 19, 2026196,260 (c)
Chief Executive Officer
Yvonne K. FranzeseAugust 20, 2025May 19, 202612,000 (d)
Chief Human Resources Officer

(a) Trading arrangement will terminate on the earlier of the date (i) stated in this column, (ii) on which the aggregate

number of shares has been sold, or (iii) on which the individual gives the designated agent notice to terminate.

(b) Aggregate shares to be sold will be subject to reduction of certain shares surrendered to satisfy required tax

withholding obligations upon future vesting events.

(c) Of these shares,133,400 are performance share grants of which the number of underlying shares to vest will depend upon achievement of certain financial metrics for the Company's 2023-2025 performance period.

(d) Of these shares,9,000 are performance share grants of which the number of underlying shares to vest will depend upon achievement of certain financial metrics for the Company's 2023-2025 performance period.

During the three months ended September 30, 2025, other than the individuals included in the table above, none of the Company's directors and no other Section 16 officers adopted, terminated or modified a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K).

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.